The study reveals that neoadjuvant immunochemotherapy significantly enhances long-term survival for patients with locally advanced esophageal squamous carcinoma, particularly those with stage III disease or suspected lymph node involvement. An analysis of 397 patients showed that while pathologic complete response rates were similar between immunochemotherapy and chemoradiotherapy groups, the former led to better overall survival […]
Category: Upper Gastrointestinal Tract
Endoscopic resection proves effective for certain esophageal tumors
The study identifies significant clinicopathological differences between esophageal gastrointestinal stromal tumors (e-gist) and gastric gastrointestinal stromal tumors (g-gist), noting e-gist’s stronger male predominance, older median age, and increased tumor size and ulceration. Remarkably, endoscopic resection (ER) is found to be comparably effective to surgical resection for selected e-gist patients (tumors ≤5 cm without ulceration), with […]
Machine learning model predicts anastomotic strictures post-surgery
A novel machine learning model demonstrates the potential to predict anastomotic strictures in patients following esophageal cancer surgery. Analyzing data from 1,549 patients, the gradient boosting machine achieved an area under the curve (AUC) of 0.886 in the training set and 0.872 in the validation set. Key predictive variables included anastomotic leakage, suture method, and […]
Refluxstop surgery shows promise for large hiatal hernia patients
A cohort study of 99 patients in Switzerland evaluated refluxstop surgery’s efficacy for treating gastroesophageal reflux disease (GERD) in those with small and large hiatal hernias (HH). The study reported no significant differences in adverse events between groups. Notable improvements in GERD-HRQL scores were found: 93.8% improvement for large HH and 85.7% for small HH […]
Laparoscopic and open surgery for T4A gastric cancer compared
A randomized controlled trial intends to evaluate the non-inferiority of laparoscopic distal gastrectomy (LDG) versus open distal gastrectomy (ODG) in treating clinically resectable T4A gastric cancer. With 240 participants, the trial will assess 3-year disease-free survival alongside secondary outcomes such as morbidity, mortality, recovery, and quality of life. This pioneering study aims to establish LDG’s […]
Smoking increases postoperative complications after esophagectomy for cancer.
A study analyzing 694 patients undergoing esophagectomy for esophageal squamous cell carcinoma revealed that smokers faced significantly higher rates of major complications and 30-day mortality compared to non-smokers. Major morbidity rates reached 37% among smokers versus 23% for non-smokers. Active smokers experienced more severe pulmonary issues and acute respiratory distress syndrome. Long-term survival rates were […]
Joint nasogastric tube proves superior for esophagojejunostomy
A novel joint nasogastric tube (JNT) significantly improved the success rate of tube insertion into the esophageal stump during overlap-esophagojejunostomy, reaching 90.6% compared to 58.5% with traditional nasogastric tubing (TNT). Insertion times decreased dramatically, with JNT taking only 15 seconds versus 100 seconds for TNT. Additionally, esophagojejunostomy time was reduced by 4.3 minutes. Postoperative complications […]
ChatGPT-4o is superior in aiding gastric cancer decisions
ChatGPT-4o significantly outperformed Gemini Advanced in generating treatment recommendations for advanced gastric cancer, as evidenced by a structured evaluation of responses to ten clinical questions. It provided superior recommendations in surgical suggestions and chemotherapy options during multidisciplinary team discussions. Additionally, it excelled in analyzing rare cases from PubMed, demonstrating increased accuracy and consistent evaluator agreement. […]
Deep learning effectively identifies pathologic complete response in esophageal cancer.
A deep neural network-based endoscopic evaluation accurately detected pathologic complete response (PCR) in esophageal cancer patients after neoadjuvant chemotherapy, achieving median sensitivity, specificity, and accuracy rates of 80%, 90%, and 85%, respectively. Among 1041 patients, 354 demonstrated PCR, correlating with significantly improved overall and recurrence-free survival. The findings suggest the potential for this AI technology […]
Timely surgery after neoadjuvant therapy improves survival rates.
A multicenter analysis of 893 gastric cancer patients revealed that surgery within 28 days of neoadjuvant therapy significantly enhances overall survival rates. Delays beyond 28 days correlated with poorer outcomes and diminished tumor regression effectiveness. Notably, patients with inadequate responses to therapy benefited most from timely surgical intervention. This research emphasizes the critical nature of […]